Home › Glycogen Storage Disease Type II › Arizona
Glycogen Storage Disease Type II clinical trials in Arizona
3 studies for Glycogen Storage Disease Type II are looking for participants at sites in Arizona.
Cities in Arizona
A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD)
- Barrow Neurological Institute, Phoenix
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Jul 20, 2026 · NCT07282847Pompe Disease Registry Protocol
- Barrow Neurological Institute- Site Number : 840087, Phoenix
- Phoenix Children's Hospital- Site Number : 840003, Phoenix
- University of Arizona- Site Number : 840015, Tucson
RecruitingObservational study
All ages · All sexes · Updated Jun 23, 2026 · NCT00231400Pompe Pregnancy Sub-Registry
- Barrow Neurol Group- Site Number : 840087, Phoenix
RecruitingObservational study
All ages · Women · Updated Apr 16, 2026 · NCT00567073From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.